| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 09/17/2009 | US20090233968 INHIBITORS OF THE ALPHA2BETA1/GPIa-IIA INTEGRIN |
| 09/17/2009 | US20090233949 Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 09/17/2009 | CA2714027A1 A process for the preparation of 2-cyanoimino-1,3-thiazolidine |
| 09/17/2009 | CA2712914A1 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/16/2009 | EP2099777A1 Urea glucokinase activators |
| 09/16/2009 | EP2099768A2 Agonists of the sphingosine-1-phosphate receptor |
| 09/16/2009 | EP2099755A2 Acetylene derivatives as stearoyl coa desaturase inhibitors |
| 09/16/2009 | EP2099754A1 Ion channel modulators |
| 09/16/2009 | EP1737450B1 Aqueous composition comprising a thiazole derivative |
| 09/16/2009 | EP1578737B1 Substituted heterocyclic compounds |
| 09/16/2009 | EP1462444B1 Intermediate for biotin and process for producing the same |
| 09/16/2009 | EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/16/2009 | CN101531621A Method for preparing guanidine compound |
| 09/16/2009 | CN100540547C Inhibitors of histone deacetylase |
| 09/16/2009 | CN100540538C Large conductance calcium-activated k channel opener |
| 09/16/2009 | CN100540534C N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides |
| 09/15/2009 | US7589216 Process for preparing N-hydroxyformamido-propyl pyrrolidin compounds and intermediates |
| 09/15/2009 | US7589213 Therapeutic substituted lactams |
| 09/15/2009 | US7589126 Useful as potent and selective activated blood coagulation factor X inhibitors, anticoagulants; for example, ethyl [4-[2-[2-hydroxy-5-(N-hydroxycarbamimidoyl)benzenesulfonyl-amino]ethyl]-2'-methanesulfonylbiphenyl-3-yloxy]acetate; brain and cardiovascular disorders |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/11/2009 | WO2009111447A2 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers |
| 09/11/2009 | WO2009110542A1 Anilide compound and use thereof |
| 09/11/2009 | WO2009109999A1 Novel protein tyrosine phosphatase - ib inhibitors |
| 09/11/2009 | WO2009109998A1 Novel protein tyrosine phosphatase - ib inhibitors |
| 09/11/2009 | WO2009109539A2 Chemical compounds |
| 09/11/2009 | WO2009109483A1 Leukotriene b4 inhibitors |
| 09/11/2009 | WO2009078981A3 Ppar-delta ligands and methods of their use |
| 09/11/2009 | WO2009071650A3 Amide compounds as boosters of antivirals |
| 09/11/2009 | CA2717202A1 Leukotriene b4 inhibitors |
| 09/11/2009 | CA2716741A1 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers |
| 09/11/2009 | CA2715835A1 Amide compounds, compositions and uses thereof |
| 09/10/2009 | US20090227790 A kit for treating a disorder characterized by loss of dopaminergic and/or motoneurons, for treating Parkinson's disease, amyotrophic lateral sclerosis (ALS), or limiting damage to neuronal cells by Parkinsonian conditions |
| 09/10/2009 | US20090227762 Novel catalytic materials and their use in the preparation of polymeric materials |
| 09/10/2009 | US20090227644 Agent for regeneration and/or protection of nerves |
| 09/10/2009 | US20090227643 3-benzyloxycarbonylmethyl-4,5-dimethyl-thiazole-3-bromide, used for improving skin elasticity or reducing wrinkles, treating diabetes, kidney damage, hypertension, vision defects, neuropathy, osteoarthritis or in teeth antisoilants and preservatives |
| 09/10/2009 | US20090227604 Vitamin d receptor modulators |
| 09/10/2009 | US20090227603 Leukotriene b4 inhibitors |
| 09/10/2009 | US20090227592 Compounds effecting glucokinase |
| 09/10/2009 | US20090226954 Labeling of target molecules, identification of organelles and other applications, novel compositions, methods and kits |
| 09/09/2009 | EP2098528A2 Biotin intermediate and process for preparing the same |
| 09/09/2009 | EP2098120A2 2-alkyl-cycloalk(en) yl-carboxamides |
| 09/09/2009 | EP2097382A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase |
| 09/09/2009 | EP2097379A1 Carboxamide derivatives as ion channel modulators |
| 09/09/2009 | EP1809284A4 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 09/09/2009 | EP1773794A4 AN IMPROVED PROCESS FOR PREPARING N-HYDROXY-4-[5- [4- (5-ISOPROPYL-2-METHYL-l, 3-THIAZOL-4-YL) -PHENOXY] -PENTOXY]-BENZAMIDINE |
| 09/09/2009 | EP1379243B1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 09/09/2009 | CN101528718A Modulators of glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof |
| 09/09/2009 | CN101525319A Febuxostat and drug combination thereof |
| 09/09/2009 | CN101525315A Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole |
| 09/09/2009 | CN100537551C Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents |
| 09/08/2009 | US7585998 Method for producing difluoro-acetyl-acetic acid alkylesters |
| 09/08/2009 | US7585979 Process for preparing N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)-phenoxy]-pentoxy}-benzamidine |
| 09/08/2009 | US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 09/08/2009 | US7585880 Phenylpropanoic acid derivatives |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | CA2314339C N-benzyl-3-indenylacetamide derivatives for treating neoplasia |
| 09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/03/2009 | WO2009105906A1 Flavor molecules |
| 09/03/2009 | WO2009086163A3 Thiazolylidine urea and amide derivatives and methods of use thereof |
| 09/03/2009 | WO2009068170A3 2-(benzyl- and 1h-pyrazol-4-ylmethyl)sulfinyl thiazole derivatives as herbicides and plant growth regulators |
| 09/03/2009 | US20090221817 Triethylamine was added dropwise to a solution of 2-methylpropane-2-sulfinyl chloride and methyl trans-4-amino-1-cyclohexane carboxylate p-toluenesulfonate in tetrahydrofuran solvent to obtain Methyl trans-4-(2-methylpropane-2-sulfonylamino)cyclohexanecarboxylate; hydrolysis; oxidation; intermediates |
| 09/03/2009 | US20090221654 Prostaglandin e1 and e2 analogs for the treatment of various medical conditions |
| 09/03/2009 | US20090221653 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3H)-one-derivatives as beta2 adrenoreceptor agonists |
| 09/03/2009 | US20090221635 Quinolinyl and benzothiazolyl modulators |
| 09/03/2009 | US20090221604 Thiazole Compounds and Their Use as PGD2 Antagonists |
| 09/03/2009 | US20090221442 Substrates and screening methods for transport proteins |
| 09/03/2009 | US20090220662 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/02/2009 | EP2096112A2 Thiazoline acid derivatives |
| 09/02/2009 | EP2094676A2 New process for the preparation of 2-imino-thiazolidin-4-one derivatives |
| 09/02/2009 | EP2094638A2 2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them |
| 09/02/2009 | CN101522648A Arginine derivatives with np-i antagonistic activity |
| 09/02/2009 | CN101522647A Substituted azolin-2-yl-amino compounds |
| 09/02/2009 | CN101519386A Large conductance calcium-activated K channel opener |
| 09/02/2009 | CN100534988C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 09/01/2009 | US7582769 enzyme inhibitor for treating diabetes; 1-(4-Methyl-cyclohexyl)-3-(5-methyl-thiazol-2-yl)-1-(4-oxo-cyclohexyl)-urea |
| 09/01/2009 | US7582765 Aryl aniline β2 adrenergic receptor agonists |
| 09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 09/01/2009 | US7582665 Heterocyclic sulfur compounds and/or prodrugs administered for prophylaxis of thrombocytopenia, anemia or blood disorders |
| 09/01/2009 | US7582664 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582632 Tri(cyclo) substituted amide compounds |
| 09/01/2009 | CA2506491C Novel derivatives of pyrrolidines and thiazolidines, process for preparing them and pharmaceutical compositions containing them |
| 08/27/2009 | WO2009105026A1 Compound (r) -n*6*-ethyl-6, 7-dihydro-5h-indeno (5, 6- d) thiazole-2, 6-diamine and the use as antipsychotics |
| 08/27/2009 | WO2009104200A1 A method for preparation of thiazolidinedione derivatives |
| 08/27/2009 | WO2009103432A2 Covalently binding imaging probes |
| 08/27/2009 | WO2008113056A3 Synthesis of chirally purified substituted benzothiazole diamines |
| 08/27/2009 | US20090216017 Process for producing biaryl compound |
| 08/27/2009 | US20090216013 e.g.1,1-Dicyclohexyl-3-[5-(pyridin-2-ylsulfanyl)-thiazol-2-yl]-urea; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
| 08/27/2009 | US20090215841 D2 Receptor Ligand-078 |
| 08/27/2009 | US20090215827 Inhibitors of cxcr2 |
| 08/27/2009 | US20090215800 Enzyme and Receptor Modulation |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215758 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs |
| 08/27/2009 | US20090215749 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor |
| 08/27/2009 | US20090211038 Hemicyanin styryl thiol/disulfide dye, composition comprising hemicyanin styryl thiol/disulfide dye, and method for lightening keratin materials using hemicyanin styryl thiol/disulfide dye |
| 08/27/2009 | CA2716215A1 Compound (r) -n*6*-ethyl-6, 7-dihydro-5h-indeno (5, 6- d) thiazole-2, 6-diamine and the use as antipsychotics |
| 08/26/2009 | EP2093220A2 Inhibitors of fatty acid amide hydrolase |
| 08/26/2009 | EP2091955A1 Alkoxy compounds for disease treatment |